Kelle Jones

Chief Financial Officer at Pamlico BioPharma, Inc.

Kelle Jones

Kelle Jones

Chief Financial Officer at Pamlico BioPharma, Inc.

Biography

Ms. Kelle Jones, CPA, is a Chief Financial Officer at Pamlico BioPharma, Inc.

Overview
Career Highlights

Otologic Pharmaceutics, Inc.
Pamlico BioPharma, Inc.

RelSci Relationships

678

Relationships
RelSci Relationships are individuals Kelle Jones likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Operating Officer at Pamlico BioPharma, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Pamlico BioPharma, Inc.

Relationship likelihood: Strong

Co-Founder at Otologic Pharmaceutics, Inc.

Relationship likelihood: Average

Co-Founder at Otologic Pharmaceutics, Inc.

Relationship likelihood: Average

Co-Founder at Otologic Pharmaceutics, Inc.

Relationship likelihood: Average

Former Senior Director, Product Management at Microsoft Corporation

Relationship likelihood: Weak

Senior Vice President, Chief Medical Officer at Audentes Therapeutics, Inc.

Relationship likelihood: Weak

Senior Vice President, Human Resources at ARIAD Pharmaceuticals, Inc.

Relationship likelihood: Weak

Chief Commercial Officer at Anika Therapeutics, Inc.

Relationship likelihood: Weak

Principal Engineer at Sanofi Genzyme

Relationship likelihood: Weak

Paths to Kelle Jones
Potential Connections via
Relationship Science
You
Kelle Jones
Chief Financial Officer at Pamlico BioPharma, Inc.
Education
B.S Business Administration, Accounting

Oklahoma State University (also referred to informally as Oklahoma State, OKState, O-State, and OSU) is a land-grant, sun-grant, coeducational public research university located in Stillwater, Oklahoma, United States. OSU was founded in 1890 under the Morrill Act. Originally known as Oklahoma Agricultural and Mechanical College (Oklahoma A&M), it is the flagship institution of the Oklahoma State University System. Official enrollment for the fall 2010 semester system-wide was 35,073, with 23,459 students enrolled at OSU-Stillwater. Enrollment shows the Freshman class of 2012 was the largest on record with 4,298 students. OSU is classified by the Carnegie Foundation as a research university with high research activity.

Career History
Chief Financial Officer
2014 - Current

Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK.

Chief Financial Officer
Current

Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK.

Senior Accountant & Site Controller
Prior

Genzyme Corp. develops and manufactures specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kelle Jones. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kelle Jones's profile does not indicate a business or promotional relationship of any kind between RelSci and Kelle Jones.